Regulation of frameshifting by puromycin. (A) pEF-FSmtLuc and pEF-FSPSmtLuc constructs were transfected into Huh7 cells along with the growth hormone plasmid, which was used to monitor the transfection efficiency. After 24 h, cells were treated with puromycin for another 24 h, harvested, and analyzed for luciferase activity. The experiment was done in duplicates, which were repeated at least three times. Data represent the mean ± SEM of a typical set of experiments. The fold increase in frameshift efficiency was calculated by dividing the frameshift efficiency of puromycin-treated samples by that of the untreated samples. (B) pCMV-G-Core and pCMV-G-CoreΔ constructs were used for the synthesis of RNA, which was then translated in vitro, using wheat germ extracts in the presence of [35S]methionine and 0 to 5 μM puromycin. Products were analyzed by gel electrophoresis, followed by autoradiography. (C) Protein products shown in panel B were quantitated by densitometry. Frameshift efficiency was calculated by determining the intensity of G-F protein or G-1.5-kDa protein bands divided by that of the G-core protein at each puromycin concentration, taking into consideration the number of methionine residues in each protein. The fold changes in these frameshift efficiencies from that of the untreated control (0 μM puromycin) were then plotted against the puromycin concentration. Similar results were obtained using rabbit reticulocyte lysates (data not shown).